Borderline Personality Disorder Clinical Trial
Official title:
Process-Outcome Study on Psychotherapeutic Interventions in Adolescents With Personality Disorders
NCT number | NCT02518906 |
Other study ID # | EAST |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | September 2015 |
Est. completion date | November 2020 |
Verified date | April 2021 |
Source | University Hospital, Basel, Switzerland |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Specialized treatment of personality disorders (PD) in youth has been neglected for a long time, because these disorders were not diagnosed before the age of 18. Since 2013 the age threshold has been dropped in the Diagnostic and Statistical Manual (DSM)-5, and such change is also announced for the International Classification of Diseases (ICD)-11. There is broad consensus from both scientific evidence and clinical experience that specialized early interventions in adolescents with PD are urgently needed. In the last decades a number of specialized psychotherapeutic treatment programs have been developed. Despite their conceptual differences, many of the treatment models have shown significant effects in the treatment of PD in adults. However, the treatment of adolescents with PD remains difficult and further enhancement and development of treatments is needed. Given the different therapeutic approaches available, the present project aims to go beyond the comparison of integral therapeutic models in the classical outcome study design. While outcome research is important to build on the evidence of the effectiveness of an intervention, it contributes little to its understanding and refinement. The aim of the present multi-center project is to compare two therapeutic methods used in routine care: - Adolescent Identity Treatment (AIT) - Dialectic Behavioral Treatment for Adolescents (DBT-A) Treatments will be performed at different study centers and compared using the same measures of outcome. The main outcome will be psychosocial functioning. Additionally, the psychotherapy process will be investigated to explore specific and unspecific mechanisms of the therapeutic process, its outcome and mediators.
Status | Completed |
Enrollment | 60 |
Est. completion date | November 2020 |
Est. primary completion date | September 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 13 Years to 19 Years |
Eligibility | Inclusion Criteria: - Identity Diffusion (AIDA T-score > 60) - borderline Criteria (SKID-II) Exclusion Criteria: - intelligence quotient (IQ) < 80 - psychotic disorder - pervasive developmental disorders - heavy and persistent substance abuse - major somatic or neurological disease - hospital treatment |
Country | Name | City | State |
---|---|---|---|
Chile | Millennium Institute for Research in Depression and Personality - Pontificia Universidad Católica de Chile | Santiago de Chile | |
Germany | Department of Child and Adolescent Psychiatry, Centre for Psychosocial Medicine, University of Heidelberg | Heidelberg | |
Switzerland | Psychiatric Universitiy Hospital Basel | Basel |
Lead Sponsor | Collaborator |
---|---|
Klaus Schmeck | Heidelberg University, Pontificia Universidad Catolica de Chile |
Chile, Germany, Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Children's Global Assessment Scale (CGAS) | Psychosocial functioning. Rated considering the results of the Columbia Impairment Scale - parent and patient versions | Baseline, 12 months after Baseline | |
Secondary | Psychosocial functioning | Columbia Impairment Scale (CIS) (Patient and Parent versions) | Baseline, 12 months after Baseline | |
Secondary | School functioning | School Functioning Rating (SFR) | Baseline, 12 months after Baseline | |
Secondary | Change in Psychopathology | Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID) | Baseline, 12 months after Baseline (only Basel and Heidelberg) | |
Secondary | Change in Severity of Psychopathology | Clinical Global Impression Scale | Baseline, 12 months after Baseline | |
Secondary | Change in Depression | Beck Depression Inventory (BDI) | Baseline, 12 months after Baseline | |
Secondary | Change in Psychopathological Symptoms | Strengths & Difficulties Questionnaires (SDQ) | Baseline, 12 months after Baseline | |
Secondary | Change in Personality Functioning | Levels of Personality Functioning - Questionnaire for Adolescents (LoPF-QA) | Baseline, 12 months after Baseline (only Basel and Heidelberg) | |
Secondary | Change in Identity | Assessment of Identity Development in Adolescence (AIDA) | Baseline, 12 months after Baseline | |
Secondary | Change in Personality Disorder Symptoms | Structured Clinical Interview of Diagnostic and Statistical Manual of Mental Disorders (DSM) (SCID)-II | Baseline, 12 months after Baseline (only Basel and Heidelberg) | |
Secondary | Change in Interpersonal Problems | Inventory of Interpersonal Problems (IIP-64) | Baseline, 12 months after Baseline (only Santiago) | |
Secondary | Change in Mentalizing Capacity | Movie for the Assessment of Social Cognition (MASC) | Baseline, 12 months after Baseline | |
Secondary | Change in Quality of Life | Health-related Quality of Life Screening Instrument for Children and Adolescents (KIDSCREEN) | Baseline, 12 months after Baseline | |
Secondary | Change in Parental Stress | Eltern-Belastungs-Inventar (EBI) | Baseline, 12 months after Baseline (only Basel and Heidelberg) | |
Secondary | Self-injurious Behavior | Self- Injurious Thoughts and Behaviors Interview | Baseline, 12 months after Baseline (only Basel and Heidelberg) | |
Secondary | Borderline-specific Personality Pathology | Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD) | Baseline, 12 months after Baseline (only Basel and Heidelberg) | |
Secondary | Borderline-specific Symptoms | Borderline Symptom List 23 (BSL-23) | Baseline, 12 months after Baseline (only Basel and Santiago) | |
Secondary | Change in Psychophysiological Measures (Only Basel and Heidelberg) | Regression analysis will be used to evaluate change; Parameters: Heart Rate Variability and Electrodermal Activity (Basel only) | Baseline, 12 months after Baseline | |
Secondary | Change in Hair Cortisol Level (only Basel and Heidelberg) | Baseline, 12 months after Baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04856449 -
DBT Skills Plus EMDR for BPD and Trauma
|
N/A | |
Active, not recruiting |
NCT04587518 -
Five Factor Model Treatment for Borderline Personality Disorder
|
N/A | |
Recruiting |
NCT05651295 -
A Precision Medicine Approach to Target Engagement for Emotion Regulation
|
N/A | |
Completed |
NCT03677037 -
The Short-Term MBT Project
|
Phase 3 | |
Not yet recruiting |
NCT05989529 -
Delving Into Borderline Personality Disorder Clinical Trial Experiences
|
||
Completed |
NCT02068326 -
MBT in Groups for Adolescents With BPD or Subthreshold BPD Versus TAU - the M-GAB Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT04296604 -
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
|
N/A | |
Terminated |
NCT02149823 -
Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations
|
Phase 1 | |
Completed |
NCT02108990 -
Acetaminophen and Social Processes
|
Phase 2 | |
Not yet recruiting |
NCT01683136 -
Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Feasibility Study for the Treatment of Borderline Personality Disorder
|
N/A | |
Completed |
NCT01635556 -
Evaluation of a Modified Dialectical Behavior Therapy Program
|
N/A | |
Completed |
NCT02988037 -
Adapted Dialectical Behaviour Therapy for Adolescents With Deliberate Self-Harm: A Pre-post Observational Study
|
N/A | |
Completed |
NCT02397031 -
Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder
|
N/A | |
Terminated |
NCT01103180 -
Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder
|
Phase 2 | |
Terminated |
NCT01212588 -
Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD)
|
Phase 2 | |
Terminated |
NCT00539188 -
N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD
|
Phase 2 | |
Recruiting |
NCT05398627 -
Neurofeedback for Borderline Personality Disorder
|
N/A | |
Recruiting |
NCT03994510 -
SHame prOpensity in bOrderline Personality Disorder
|
N/A | |
Recruiting |
NCT06005129 -
Personality Change Study for Borderline Personality Disorder
|
N/A | |
Recruiting |
NCT06406972 -
Brief Admission by Self-referral for Individuals With Self-harm: Effects on Compulsory Care
|